Earnings History Data for Aldeyra Therapeutics (ALDX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aldeyra Therapeutics

Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-03-2024	AH		ALDX	Aldeyra Therapeutics	231.00	-0.08	-0.21	0.00		3.61	-0.24 (-6.21%)	3.78	-0.07 (-1.76%)	1.42 - 11.97	732,452	520,000	5,084
Aldeyra Therapeutics files for $200M mixed securities shelf [3/7/2024 5:00 PM]
09-03-2023	PM	7:00 AM ET (Mar 9)	ALDX	Aldeyra Therapeutics, Inc.	406.41	-0.22	-0.34	-0.27	Aldeyra Therapeutics GAAP EPS of -$1.06 beats by $0.10 [3/9/2023 7:03 AM]	7.89	0.52 (7.06%)	7.75	0.38 (5.12%)	2.36 - 7.99	818,341	470,000	1,494
Aldeyra Therapeutics GAAP EPS of -$1.06 beats by $0.10 [3/9/2023 7:03 AM]
10-11-2022	PM	7:00 AM ET (Nov 10)	ALDX	Aldeyra Therapeutics, Inc.	316.11	-0.25	-0.34	-0.27	Aldeyra Therapeutics GAAP EPS of -$0.25 beats by $0.10 [11/10/2022 7:02 AM]	5.53	0.35 (6.76%)	5.10	-0.08 (-1.54%)	2.36 - 9.35	624,001	260,000	959
Aldeyra Therapeutics Q3 2022 Earnings Preview [11/9/2022 1:32 PM] Aldeyra Therapeutics GAAP EPS of -$0.25 beats by $0.10 [11/10/2022 7:02 AM]
05-08-2022	PM	7:00 AM ET (Aug 5)	ALDX	Aldeyra Therapeutics, Inc.	304.33	-0.30	-0.32	-0.28	Aldeyra Therapeutics GAAP EPS of -$0.30 beats by $0.02 [8/5/2022 7:05 AM]	6.92	0.68 (10.90%)	6.92	0.0 (0.00%)	2.35 - 10.19	2,065,763	790,000	1,437
Aldeyra Therapeutics GAAP EPS of -$0.30 beats by $0.02 [8/5/2022 7:05 AM] Aldeyra Therapeutics stock rises 13% on Q2 beat with eyes on approval path for reproxalap [8/5/2022 12:21 PM] Aldeyra Therapeutics Reports Second-Quarter 2022 Financial Results and Recent Corporate Highlights [Aug-05-22 07:00AM] Joseph Edelman Just Bought 2.2% More Shares In Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) [Aug-05-22 06:09AM]
05-05-2022	PM	7:00 AM ET (May 5)	ALDX	Aldeyra Therapeutics, Inc.	177.82	-0.29	-0.31	-0.25	Aldeyra Therapeutics GAAP EPS of -$0.29 beats by $0.04 [5/5/2022 7:19 AM]	2.79	-0.14 (-4.95%)	2.95	0.02 (0.68%)	2.71 - 13.18	598,776	870,000	177,776
Aldeyra Therapeutics Q1 2022 Earnings Preview [5/4/2022 2:14 PM] Aldeyra Therapeutics GAAP EPS of -$0.29 beats by $0.04 [5/5/2022 7:19 AM] Aldeyra Therapeutics to Present at MOD Live! 2022 Meeting [May-04-22 08:30AM] Aldeyra Therapeutics Reports First-Quarter 2022 Financial Results and Recent Corporate Highlights [May-05-22 07:00AM]
17-03-2022	PM	7:00 AM ET (Mar 17)	ALDX	Aldeyra Therapeutics, Inc.	223.65	-0.27	-0.31	-0.35	Aldeyra Therapeutics GAAP EPS of -$1.07 beats by $0.02 [3/17/2022 7:01 AM]	4.87	0.69 (16.51%)	4.51	0.33 (7.89%)	3.00 - 15.95	1,070,275	1,266,838	12,378
Aldeyra Therapeutics GAAP EPS of -$1.07 beats by $0.02 [3/17/2022 7:01 AM] Aldeyra Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights [Mar-17-22 07:00AM]
28-10-2021	PM	7:00 AM ET (Oct 28)	ALDX	Aldeyra Therapeutics, Inc.	463.49	-0.27	-0.29	-0.23	Aldeyra Therapeutics EPS misses by $0.01 [10/28/2021 7:10 AM]	9.00	0.76 (9.22%)	8.21	-0.03 (-0.36%)	6.21 - 15.95	749,617	500,000	122
Aldeyra Therapeutics EPS misses by $0.01 [10/28/2021 7:10 AM] Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights [Oct-28-21 07:00AM]
05-08-2021	PM	7:00 AM ET (Aug 5)	ALDX	Aldeyra Therapeutics, Inc.	515.80	-0.28	-0.27	-0.25	Aldeyra Therapeutics EPS misses by $0.03 [8/5/2021 7:08 AM]	9.57	0.73 (8.26%)	9.00	0.16 (1.81%)	5.53 - 15.95	496,459	490,000	311
Aldeyra Therapeutics shares rise after FDA orphan drug status for ADX-2191 [8/4/2021 8:22 AM] Aldeyra Therapeutics EPS misses by $0.03 [8/5/2021 7:08 AM] Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa [Aug-04-21 08:00AM] Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights [Aug-05-21 07:00AM]
06-05-2021	PM	7:00 AM ET (May 6)	ALDX	Aldeyra Therapeutics, Inc.	570.05	-0.25	-0.29	-0.34	Aldeyra Therapeutics EPS beats by $0.01 [5/6/2021 7:12 AM]	12.05	0.08 (0.67%)	12.05	0.0 (0.00%)	2.73 - 15.95	1,383,844	10,830,000	4,829
Aldeyra Therapeutics EPS beats by $0.01 [5/6/2021 7:12 AM] Aldeyra Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Highlights [May-06-21 07:00AM] Aldeyra Therapeutics, Inc. to Host Earnings Call [May-06-21 06:15AM]
11-03-2021	PM	7:00 AM ET (Mar 11)	ALDX	Aldeyra Therapeutics, Inc.	486.76	-0.35	-0.27	-0.47	Aldeyra Therapeutics EPS misses by $0.02 [3/11/2021 7:09 AM]	12.07	-0.01 (-0.08%)	11.50	-0.58 (-4.80%)	1.48 - 14.62	558,145	617,868	4,644
Aldeyra Therapeutics EPS misses by $0.02 [3/11/2021 7:09 AM] Aldeyra Therapeutics to Present at the OIS Dry Eye Innovation Showcase on March 11, 2021 [Mar-10-21 08:00AM] Aldeyra Therapeutics, Inc. to Host Earnings Call [Mar-11-21 05:15AM] Aldeyra Therapeutics Reports Full-Year 2020 Financial Results and Recent Business Highlights [Mar-11-21 07:00AM] Aldeyra Therapeutics (ALDX) Q4 2020 Earnings Call Transcript [Mar-11-21 07:00PM]
05-11-2020	PM	7:00 AM ET (Nov 5)	ALDX	Aldeyra Therapeutics, Inc.	256.91	-0.23	-0.28	-0.69	Aldeyra Therapeutics EPS beats by $0.04 [11/5/2020 7:20 AM]	6.93	0.14 (2.06%)	6.95	0.02 (0.29%)	1.48 - 8.70	572,698	493,969	15,799

06-08-2020	PM	7:00 AM ET (Aug 6)	ALDX	Aldeyra Therapeutics, Inc.	225.13	-0.25	-0.34	-0.49	Aldeyra Therapeutics EPS beats by $0.09 [8/6/2020 7:34 AM]	6.66	-0.80 (-10.72%)	6.98	-0.48 (-6.43%)	1.48 - 8.05	911,295	1,167,016	85,046